一、本次搬迁补偿事项概述 中金辐照股份有限公司（以下简称公司）子公司深圳市金鹏源辐 照技术有限公司（以下简称深圳金鹏源）为配合深圳市光明区光明街 道白花片区连片产业用地土地整备工作，于 2025 年 4 月 3 日与光明 街道办、深业明瑞签署了《搬迁补偿安置协议》及《补充协议》，具 体内容详见公司于 2025 年 4 月 7 日披露的《中金辐照股份有限公司 关于子公司签署搬迁补偿安置协议及补充协议的进展公告》（公告编 号：2025-010）。 证券代码：300962 证券简称：中金辐照 公告编号：2025-114 中金辐照股份有限公司关于子公司收到 搬迁补偿款的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 公司及深圳金鹏源将持续加强与协议相关方沟通，敦促其履行合 同义务，尽快支付剩余搬迁补偿款项。 公司董事会将密切关注搬迁补偿事项进展情况，按照中国证监会 《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市规 则》等相关法规要求，及时履行信息披露义务。 特此公告。 中金辐照股份有限公司董事会 2025 年 12 月 12 日 二、收到搬迁补偿 ...

Group 1 - The core point of the article highlights that the number of shareholders for Zhongjin Fuzhao decreased to 16,259 as of December 10, representing a decline of 1,098 shareholders or 6.33% compared to the previous period [2] - The closing price of Zhongjin Fuzhao was reported at 16.54 yuan, remaining flat, with a cumulative decline of 9.47% in stock price since the concentration of shares began, showing 3 days of increase and 6 days of decrease [2] - The company's third-quarter report indicates that it achieved a total operating revenue of 278 million yuan, reflecting a year-on-year growth of 2.33%, while net profit was 89.81 million yuan, a decrease of 6.35% year-on-year, with basic earnings per share at 0.3402 yuan and a weighted average return on equity of 9.20% [2]

（文章来源：证券日报） 本报讯 （记者李昱丞）近日，国家标准《医疗产品灭菌辐射第1部分：医疗器械灭菌过程的开发、确认 和常规控制要求》在全国标准信息公共服务平台正式发布。 这一标准将进一步规范医疗产品灭菌行业的发展，为医疗器械辐射灭菌的流程开发、效果确认及常规控 制提供清晰指导。通过加强规范医疗产品辐射灭菌过程的具体要求，能让相关企业的灭菌操作更具规范 性，确保灭菌过程更可靠、效果达标，最终保障灭菌后的产品达到预期的无菌标准，且在保质期内持续 符合质量要求。 据官网介绍，中金辐照是中国黄金集团旗下专业从事辐照技术应用的高新技术企业，专注于产品辐照灭 菌、材料辐照改性等技术的研发与应用。中金辐照深耕行业数十载，积累了丰富的经验，深度参与了辐 照加工行业标准制定，其中包括医疗保健产品、食品、无菌包装材料辐照灭菌、辐照剂量确定等19项国 家标准、行业标准、团体标准的制修订。 该标准由中金辐照股份有限公司（简称"中金辐照"）等单位参与起草编制，归口管理部门为国家药监 局，将于2029年1月1日正式施行。 ...

Market Overview - The professional services sector experienced a decline of 0.59% on December 2, with Zhongjin Radiation leading the drop [1] - The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1] Stock Performance - Notable gainers in the professional services sector included: - Xince Standard (300938) with a closing price of 35.45, up 3.20% and a trading volume of 124,200 shares, totaling 430 million yuan [1] - Lansiqimi (300795) closed at 15.90, up 2.19% with a trading volume of 112,800 shares, totaling 178 million yuan [1] - Conversely, significant decliners included: - Zhongquanfuzhao (300962) with a closing price of 17.99, down 4.56% and a trading volume of 107,800 shares, totaling 25.66 million yuan [2] - Anbang Guard (603373) closed at 41.24, down 2.80% with a trading volume of 6,815 shares, totaling 28.42 million yuan [2] Capital Flow - The professional services sector saw a net outflow of 132 million yuan from institutional investors, while retail investors experienced a net inflow of 89.54 million yuan [2] - The detailed capital flow for selected stocks showed: - Xince Standard (300938) had a net inflow of 30.20 million yuan from institutional investors, while retail investors had a net outflow of 16.85 million yuan [3] - Huace Testing (300012) recorded a net inflow of 6.18 million yuan from institutional investors, with a net outflow of 7.52 million yuan from retail investors [3]

Core Viewpoint - Zhongjin Irradiation (300962.SZ) announced a plan to issue A-shares to specific investors, aiming to raise up to RMB 800 million for various sterilization projects and working capital [1][2]. Group 1: Fundraising Details - The total amount to be raised is capped at RMB 80,000,000, which will be used for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1]. - The issuance will target no more than 35 specific investors, including China National Gold Group, which will subscribe RMB 10,000,000 worth of shares [1]. - The number of shares issued will not exceed 30% of the total share capital prior to the issuance, amounting to a maximum of 79,200,569 shares [1]. Group 2: Pricing and Financial Performance - The issuance will adopt a bidding method, with the price set at no less than 80% of the average trading price over the 20 trading days prior to the pricing date or the higher of the latest audited net asset value per share [2]. - For the first three quarters of 2025, Zhongjin Irradiation reported revenue of RMB 278 million, a year-on-year increase of 2.33%, while net profit attributable to shareholders decreased by 6.35% to RMB 89.81 million [2]. - The net profit excluding non-recurring gains and losses was RMB 78.99 million, down 15.35% year-on-year, with net cash flow from operating activities at RMB 130 million [2].

Core Viewpoint - The company, Zhongjin Ruzhao, plans to raise up to 800 million yuan through a private placement to fund several sterilization technology projects and supplement working capital, with the controlling shareholder, China National Gold Group, participating in the investment [1][2]. Group 1: Fundraising and Investment Projects - Zhongjin Ruzhao intends to issue shares to no more than 35 specific investors, including China National Gold Group, to raise funds for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1][2]. - The total investment for the Changsha and Hefei projects is 400 million yuan, with planned fundraising allocations of 100 million yuan and 200 million yuan respectively, yielding after-tax internal rates of return of 11.35% and 8.51% [2]. - The company also plans to invest 100 million yuan in the second phase of the annual sterilization medical device project at Zhongjin Health Technology (Jiaxing), which has a total investment of 108 million yuan [2]. Group 2: Operational Strategy and Market Position - The company has established a national presence with service areas including Shenzhen, Shanghai, Tianjin, Qingdao, Wuhan, Chengdu, Chongqing, and Jiaxing, aiming to enhance regional connectivity and market share through the new projects [3]. - Zhongjin Ruzhao's main business segments include irradiation technology services, disinfection supply services, and technical testing services, with irradiation technology being the primary source of revenue and profit [3]. - The company has formed long-term strategic partnerships with over 30 Fortune 500 companies, serving various industries such as healthcare, food, pharmaceuticals, daily necessities, and packaging materials [3]. Group 3: Financial Performance - For the first three quarters of 2025, Zhongjin Ruzhao reported revenues of 278 million yuan and a net profit of 89.81 million yuan, reflecting a year-on-year decline of 6.35% [4].

Key Points - The article highlights various significant announcements from companies, including investment projects, share buybacks, and contract wins [1][2][3] Group 1: Company Announcements - Qin'an Co., Ltd. has a small external circulation and a high recent turnover rate, indicating potential risks [1][2] - Rongtai Health plans to acquire a 21% stake in Youmo Youyang for 42 million yuan [2] - Huaitong Holdings intends to invest 1 billion yuan to construct 900,000 high-end new energy vehicle styling components and acoustic products [1][2] Group 2: Investment Projects - COFCO Technology plans to invest in a new project for 250,000 tons/year of starch sugar and 10,000 tons/year of alulose in Pingliang [1] - Haili Wind Power aims to collaborate on the construction and operation of the Wenzhou mother port phase one project [1] - Wolong New Energy proposes an 800 million yuan investment for a 200,000 kW/1.2 million kWh grid-side independent energy storage demonstration project in Baotou [1] Group 3: Contract Wins - Wansheng Intelligent has won a contract worth 42.9866 million yuan from the State Grid [1] - Teruid has a pre-bid for a railway project valued at 94.8792 million yuan [1] - China Electric Environmental Protection signed a contract for a 125.7 million yuan water treatment project for Shanxi Coal Chemical [1] Group 4: Share Buybacks - Huaitong Holdings plans to repurchase shares worth 30 million to 50 million yuan [2] - Yongtai Energy intends to repurchase shares for 300 million to 500 million yuan for cancellation [2] Group 5: Shareholding Changes - Hengyi Petrochemical's controlling shareholder and its concerted parties plan to increase their holdings by 1.5 billion to 2.5 billion yuan [3] - Multiple shareholders of Green通科技 plan to reduce their holdings by up to 4% [3] - Shareholders of Chip Origin plan to reduce their holdings by up to 1.15% [3]

Key Points - Qin'an Co., Ltd. has a small external circulation and a high recent turnover rate, indicating potential risks [1][2] - Rongneng Technology expects to generate approximately 16.78 million yuan in revenue from the robotics sector in the first three quarters of 2025, accounting for about 1.02% of the company's total revenue [1] - Huaitong Holdings plans to invest 1 billion yuan to construct 900,000 high-end new energy vehicle styling components and acoustic products [1] - Wansheng Intelligent has won a bid for a State Grid project worth 42.9866 million yuan [1] - Ningbo Fubang intends to transfer 2.50% equity of China Paper for 370 million yuan [1][2] - Yongtai Energy plans to repurchase shares worth 300 million to 500 million yuan for cancellation [1][2] - Hengyi Petrochemical's controlling shareholder and its concerted parties plan to increase their holdings by 1.5 billion to 2.5 billion yuan [1][3] - Meidike intends to raise no more than 700 million yuan through a private placement for MEMS device optical system manufacturing projects [1][3] - Zhongjin Irradiation plans to raise no more than 800 million yuan through a private placement to its controlling shareholder and others [1][3]

格隆汇12月1日丨中金辐照(300962.SZ)公布，拟定增募集资金总额不超过人民币80,000.00万元，扣除相 关发行费用后的募集资金净额用于中金辐照长沙灭菌技术服务中心项目、合肥市综合灭菌技术中心项 目、中金健康科技（嘉兴）有限公司年灭菌医疗器械30万立方米项目二期、钴源采购项目、补充流动资 金。中国黄金集团系公司控股股东，中国黄金集团以人民币10,000万元认购公司本次发行的股票，其他 股票由本次发行的其他发行对象认购。 ...

Core Viewpoint - Zhongjin Irradiation (300962.SZ) plans to issue A-shares to specific investors, including China National Gold Group, with a total fundraising amount not exceeding RMB 800 million [1][1][1] Group 1: Issuance Details - The issuance will target no more than 35 specific investors who meet the criteria set by the China Securities Regulatory Commission [1][1] - The controlling shareholder, China National Gold Group, will subscribe to the shares for RMB 100 million [1][1] Group 2: Fund Utilization - The net proceeds from the fundraising, after deducting related issuance costs, will be used for several projects, including: - Changsha Sterilization Technology Service Center Project - Hefei Comprehensive Sterilization Technology Center Project - Phase II of the annual sterilization medical device project in Jiaxing, with a capacity of 300,000 cubic meters - Cobalt source procurement project - Supplementing working capital [1][1][1]